India to Canada: Hydroxychloroquine Export Trade Route

The India to Canada Hydroxychloroquine corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $775.8K USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 84% of all export value, reflecting the consolidated nature of India's hydroxychloroquine manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $77.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with hydroxychloroquine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 17.4%, placing it at rank #10 among India's top hydroxychloroquine export destinations globally.

On the import side, key buyers of Indian hydroxychloroquine in Canada include NADA, Mint Pharmaceuticals Inc, XX ORXXR OXXMINXXPHAXXACEXXICAXX INX and 5 others. NADA is the single largest importer with 1 shipments valued at $265.1K USD.

India's hydroxychloroquine exports to Canada are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, IPCA LABORATORIES LIMITED , INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $77.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines mint hydroxychloroquine hydroxychloroquine sulfate tabletsusp 200mg 1x100s 29093x1x100s per p and mint-hydroxychloroquine (, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NADA is the largest importer with 1 shipments worth $265.1K USD — representing 34% of all hydroxychloroquine imports from India on this route. A total of 8 buyers are active on this corridor.